Skip to main content

Advertisement

SpringerLink
Log in

Is beta-blocker (atenolol) a preferred antihypertensive in acute intracerebral hemorrhage?

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

The mortality in intracerebral hemorrhage (ICH) is mainly due to raised intracranial pressure, and its complications mediated by sympathetic overactivity. There is paucity of studies evaluating the role of beta-blockers in the outcome of ICH. This study reports the role of atenolol in reducing mortality, pneumonia, systemic inflammatory response syndrome (SIRS), and 3 months outcome in the patients with hypertensive ICH. 138 consecutive patients with hypertensive ICH were included and their stroke risk factors and clinical details were recorded. Consciousness was assessed by Glasgow Coma Scale and severity of stroke by Canadian Neurological Scale. Volume of hematoma was measures on CT scan and occurrence of SIRS and pneumonia were noted. 3 months outcome was categorized into good (Barthel index >12) and poor (BI < 12). The patients were categorized into those receiving atenolol and nonatenolol. The effects of atenolol on stroke outcome parameters were evaluated. Seventy-nine patients received atenolol and 59 did not and they mainly received amlodipine. There was no difference in the base line clinical characteristics between the two groups except smoking (P = 0.01) and baseline blood pressure (P = 0.007). Atenolol significantly reduced the mortality (11.4 vs 37.3 %, P < 0.0001), SIRS (16.4 vs 40.9 %, P = 0.007), and pneumonia (8.9 vs 30.5 %, P = 0.002) compared to those not receiving atenolol. At 3 months, patients with atenolol had insignificantly better outcome compared to nonatenolol group (49.1 vs 31.9 %, P = 0.11). Use of atenolol in hypertensive ICH results in reduction in mortality, SIRS, and pneumonia which may be due to its β-adrenergic blocking effect.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Robinson TG, James M, Youde J, Panerai R, Potter J (1997) Cardiac baroreceptor sensitivity is impaired after acute stroke. Stroke 28:1671–1676

    Article  PubMed  CAS  Google Scholar 

  2. Oppenheimer S (1993) The anatomy and physiology of cortical mechanisms of cardiac control. Stroke 24:I3–I5

    PubMed  CAS  Google Scholar 

  3. Murros K, Fogelholm R, Kettunen S, Vuorela AL (1993) Serum cortisol and outcome of ischemic brain infarction. J Neurol Sci 116:12–17

    Article  PubMed  CAS  Google Scholar 

  4. Wang J, Dore S (2007) Inflammation after intracerebral hemorrhage. J Cereb Blood Flow Metab 27:894–908

    Article  PubMed  CAS  Google Scholar 

  5. Borrello F, Beahan M, Klein L, Gheorghiade M (2003) Reappraisal of betablocker therapy in the acute and chronic post-myocardial infarction period. Rev Cardiovasc Med 4(Suppl 3):S13–S24

    PubMed  Google Scholar 

  6. Freemantle N, Cleland J, Young P, Mason J, Harrison J (1999) Beta blockade after myocardial infarction: systematic review and meta regression analysis. BMJ 318:1730–1737

    Article  PubMed  CAS  Google Scholar 

  7. Sansing LH, Messe SR, Cucchiara BL, Lyden PD, Kasner SE (2011) Anti-adrenergic medications and edema development after intracerebral hemorrhage. Neurocrit Care 14:395–400

    Article  PubMed  CAS  Google Scholar 

  8. Cote R, Batlista RN, Wolfson C, Boucher J, Adams J, Hachinski VC (1989) The Canadian neurological scale: validation and reliability assessment. Neurology 39:638–643

    Article  PubMed  CAS  Google Scholar 

  9. American College of Chest Physician/Society of Critical Care Medicine Consensus Conference Committee (1992) Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864

    Article  Google Scholar 

  10. Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G (1993) Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke 24:987–993

    Article  PubMed  CAS  Google Scholar 

  11. Misra UK, Kalita J, Srivastav M, Mandal SK (1996) A study of prognostic predictors of supratentorial haematomas. J Neurol 243:96–100

    Article  PubMed  CAS  Google Scholar 

  12. Ay H, Arsava EM, Koroshetz WJ, Sorensen AG (2008) Middle cerebral artery infarcts encompassing the insula are more prone to growth. Stroke 39:373–378

    Article  PubMed  Google Scholar 

  13. Korpelainen JT, Sotaniemi KA, Myllyla VV (1999) Autonomic nervous system disorders in stroke. Clin Auton Res 9:325–333

    Article  PubMed  CAS  Google Scholar 

  14. Larsson PT, Wallen NH, Hjemdahl P (1994) Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin. Circulation 89:1951–1957

    Article  PubMed  CAS  Google Scholar 

  15. Prass K, Meisel C, Höflich C, Braun J, Halle E, Wolf T, Ruscher K, Victorov IV, Priller J, Dirnagl U, Volk HD, Meisel A (2003) Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med 198:725–736

    Article  PubMed  CAS  Google Scholar 

  16. Klehmet J, Harms H, Richter M, Prass K, Volk HD, Dirnagl U, Meisel A, Meisel C (2009) Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial. Neuroscience 158:1184–1193

    Article  PubMed  CAS  Google Scholar 

  17. Hachinski VC, Smith KE, Silver MD, Gibson CJ, Ciriello J (1986) Acute myocardial and plasma catecholamine changes in experimental stroke. Stroke 17:387–390

    Article  PubMed  CAS  Google Scholar 

  18. Sander D, Winbeck K, Klingelhofer J, Etgen T, Conrad B (2001) Prognostic relevance of pathological sympathetic activation after acute thromboembolic stroke. Neurology 57:833–838

    Article  PubMed  CAS  Google Scholar 

  19. Myers MG, Norris JW, Hachniski VC, Sole MJ (1981) Plasma norepinephrine in stroke. Stroke 12(2):200–204

    Article  PubMed  CAS  Google Scholar 

  20. Dziedzic T, Slowik A, Pera J, Szczudlik A (2007) Beta-blockers reduce the risk of early death in ischemic stroke. J Neurol Sci 252(1):53–56

    Article  PubMed  CAS  Google Scholar 

  21. Hasko G, Szabo C (1998) Regulation of cytokine and chemokine production by transmitters and co-transmitters of the autonomic nervous system. Biochem Pharmacol 56:1079–1087

    Article  PubMed  CAS  Google Scholar 

  22. Madden KS, Sanders VM, Felten DL (1995) Catecholamine influences and sympathetic neural mechanism of immune responsiveness. Annu Rev Pharmacol Toxicol 35:417–448

    Article  PubMed  CAS  Google Scholar 

  23. Savitz SI, Erhardt JA, Anthony JV, Gupta G, Li X, Barone FC, Rosenbaum DM (2000) The novel beta-blocker, carvedilol, provides neuroprotection in transient focal stroke. J Cereb Blood Flow Metab 20(8):1197–1204

    Article  PubMed  CAS  Google Scholar 

  24. Laowattana S, Oppenheimer SM (2007) Protective effects of beta-blockers in cerebrovascular disease. Neurology 68(7):509–514

    Article  PubMed  CAS  Google Scholar 

  25. Potter JF, Robinson TG, Ford GA, Mistri A, James M, Chernova J, Jagger C (2009) Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial. Lancet Neurol 8(1):48–56

    Article  PubMed  CAS  Google Scholar 

  26. Lindholm LH, Carlberg B, Samuelsson O (2005) Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet 366:1545–1553

    Article  PubMed  CAS  Google Scholar 

  27. Law MR, Morris JK, Wald NJ (2009) Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 338:b1665

    Article  PubMed  CAS  Google Scholar 

  28. Rost NS, Smith EE, Chang Y, Snider RW, Chanderraj R, Schwab K, FitzMaurice E, Wendell L, Goldstein JN, Greenberg SM, Rosand J (2008) Prediction of functional outcome in patients with primary intracerebral hemorrhage: the func score. Stroke 39:2304–2309

    Article  PubMed  Google Scholar 

  29. Ruiz-Sandoval JL, Chiquete E, Romero-Vargas S, Padilla-Martinez JJ, Gonzalez-Cornejo S (2007) Grading scale for prediction of outcome in primary intracerebral hemorrhages. Stroke 38:1641–1644

    Article  PubMed  Google Scholar 

  30. Katzan IL, Cebul RD, Husak SH, Dawson NV, Baker DW (2003) The effect of pneumonia on mortality among patients hospitalized for acute stroke. Neurology 60:620–625

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank Mr. Rakesh Kumar Nigam for secretarial help.

Author information

Authors and Affiliations

  1. Department of Neurology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Raebareily Road, Lucknow, 226014, India

    Jayantee Kalita, Usha Kant Misra & Bishwanath Kumar

Authors
  1. Jayantee Kalita
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Usha Kant Misra
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bishwanath Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Usha Kant Misra.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kalita, J., Misra, U.K. & Kumar, B. Is beta-blocker (atenolol) a preferred antihypertensive in acute intracerebral hemorrhage?. Neurol Sci 34, 1099–1104 (2013). https://doi.org/10.1007/s10072-012-1210-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-012-1210-y

Keywords

Search

Navigation